Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-007400
Filing Date
2018-03-14
Accepted
2018-03-14 17:31:45
Documents
2
Period of Report
2018-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2127
2 EX-24 DOCUMENT attachment1.htm EX-24 2769
  Complete submission text file 0000899243-18-007400.txt   6229
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BEIER DAVID W (Reporting) CIK: 0001187054 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38419 | Film No.: 18690389

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations